Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-10-18 | Aprea Therapeutics, Inc. | Duey Marc
(Director) |
S | Common Stock | D | 6462 | $4.58 - $4.58 | $29,583 |
2024-10-23 | Aprea Therapeutics, Inc. | Gilad Oren
(President/CEO) |
P | Common Stock | A | 500 | $3.92 - $3.92 | $1,957 |
2024-10-16 | Aprea Therapeutics, Inc. | Duey Marc
(Director) |
P | Common Stock | A | 30000 | $4.39 - $4.39 | $131,700 |
2024-10-15 | Aprea Therapeutics, Inc. | Gilad Oren
(President/CEO) |
P | Common Stock | A | 250 | $2.90 - $2.90 | $725 |
2024-10-14 | Aprea Therapeutics, Inc. | Duey Marc
(Director) |
P | Common Stock | A | 190 | $2.58 - $2.58 | $490 |
2024-10-11 | Aprea Therapeutics, Inc. | Hamill John P.
(SrVP/CFO/Prin Fin & Acct Ofcr) |
P | Common Stock | A | 50 | $2.46 - $2.46 | $123 |
2024-10-11 | Aprea Therapeutics, Inc. | Seizinger Bernd R.
(Director) |
P | Common Stock | A | 10000 | $2.68 - $2.68 | $26,800 |
2024-10-10 | Aprea Therapeutics, Inc. | Gilad Oren
(President/CEO) |
P | Common Stock | A | 1150 | $2.54 - $2.59 | $2,971 |
2024-10-10 | Aprea Therapeutics, Inc. | Hamill John P.
(SrVP/CFO/Prin Fin & Acct Ofcr) |
P | Common Stock | A | 450 | $2.61 - $2.61 | $1,174 |
2024-06-20 | Aprea Therapeutics, Inc. | Pamukcu Rifat
(Director) |
A | Common Stock | A | 1045 | $0.00 - $0.00 | $0 |
2024-06-20 | Aprea Therapeutics, Inc. | Peters Richard
(Director) |
A | Common Stock | A | 1045 | $0.00 - $0.00 | $0 |
2024-06-20 | Aprea Therapeutics, Inc. | HENNEMAN JOHN B III
(Director) |
A | Common Stock | A | 1045 | $0.00 - $0.00 | $0 |
2024-06-20 | Aprea Therapeutics, Inc. | Grissinger Michael
(Director) |
A | Common Stock | A | 1045 | $0.00 - $0.00 | $0 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |